TNNI3 and cardiac hypertrophy: Despite similar demographics, comorbidities, valve narrowing, myocardial hypertrophy, and fibrosis patients with asymmetric wall thickening have increased evidence of myocardial injury (with elevated cardiac troponin I) and BNP levels.